Reduced prolyl hydroxylase 3, which inhibits fatty acid oxidation (German et al., 2016), and increased fatty acid-binding protein 4 (Shafat et al., 2017) allow AML cells utilize fatty acids as substrates for OXPHOS. This evidence concerns the gene P3H3 and acute myeloid leukemia.